Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey - Wikidata - awgldk - TriplyDB

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

http://www.wikidata.org/entity/Q28258215

about

The latest mania: selling bipolar disorder.The prevalence of mental disorders among the homeless in western countries: systematic review and meta-regression analysis Asthma and depression: a pragmatic review of the literature and recommendations for future research Does bright light have an anxiolytic effect? - an open trial Attention-Deficit Hyperactivity Disorder in Girls Public conceptions of mental illness: labels, causes, dangerousness, and social distance Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project Social functioning in bipolar patients: the perception and perspective of patients, relatives and advocacy organizations ? a review Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders Stories behind the symptoms: a qualitative analysis of the narratives of 9/11 rescue and recovery workers Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial Construction workers struggle with a high prevalence of mental distress, and this is associated with their pain and injuries Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults Drugs versus placebo for dysthymia Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders Specialist interventions for homeless people with severe mental illness Pharmacological treatment for depression during opioid agonist treatment for opioid dependence Second-generation antipsychotics for anxiety disorders Augmentation of psychotherapy with d-cycloserine for anxiety disorders Second-generation antipsychotic drugs for anxiety disorders Combined psychotherapy plus benzodiazepines for panic disorder Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression Psychosocial and psychological interventions for treating antenatal depression Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders Lithium versus antidepressants in the long-term treatment of unipolar affective disorder Psychosocial and psychological interventions for treating antenatal depression Family therapy for depression Paraprofessionals for anxiety and depressive disorders Valerian for anxiety disorders Therapeutic touch for anxiety disorders Interventions to improve occupational health in depressed people Psychological therapies for generalised anxiety disorder Meditation therapy for anxiety disorders Therapeutic touch for anxiety disorders Antipsychotic medication for elderly people with schizophrenia Opioid antagonists for alcohol dependence

P2860

Q21090149-85D53AFC-A147-4FC6-A7D6-67E30B2C776E Q21144647-F250ADE1-21EE-4A28-A187-811C0E38ED73 Q21203792-F29BFEC0-41F4-4189-9952-A224DF09B94E Q21260272-9A47723F-C2E6-4A40-B6A1-354AB3F8AD04 Q22241431-CD13E793-F6F4-40FA-88B2-01533D810DC8 Q22241453-006EABC4-EC32-4840-86F2-80952F70650D Q22241964-BC709639-5362-4908-A7C4-3A87F5F9EE8F Q22242341-77AC6B22-2F7D-4BE0-A6E0-487A99F6908C Q22242606-7AAAA8A0-9FF8-4DE2-BC93-F276F45A78A4 Q22253031-6DAF240E-E5BF-46F8-8257-DDAFD9EFE13C Q22305681-9DED3AB4-2776-40EC-AA82-F6455A23ECA7 Q23911267-9BDE6CF0-1A48-4DD8-BCB6-D66BC70B4BB4 Q23912881-BAAF136E-99B8-43D6-85E1-8C9CDAB2048C Q23913527-879F7F23-0397-4591-BF50-8E1D48622C58 Q24186033-1B58848C-7E78-4BF7-827B-93923C0A452A Q24187378-8E0B60F0-F3D2-4B9C-AEF1-BE2448C2E744 Q24187393-34EF522F-FA82-4DEE-8E26-5A2DCE776DEF Q24187995-36D4036E-9120-4E3B-8121-43F585FB2A8F Q24202623-278B856F-A7CA-4858-BCC2-792D05666734 Q24235458-1FBE528F-868D-4331-A4E2-0542EA889522 Q24235758-3E1FC939-C774-43E4-92ED-4D6257151DCB Q24240358-B8D56CB1-BC3B-4A8F-BB6E-A2CA5976A58C Q24240919-C4EBBFF4-93B0-4074-9EB9-2131CF86B904 Q24240927-0E5DE8DA-C4C2-4B75-9E36-C6DA39C11AF8 Q24241027-54407484-78D0-47CA-AB6C-40C51DE8B2AB Q24243713-C0C984A3-B25D-4853-90B3-69EE2BB0E967 Q24243731-EF256C80-E7CC-4D24-B649-F80B22EE4382 Q24243827-BFFA5AE2-BD04-4B5B-ACF7-71DC9F1F42E3 Q24243883-A334AA1D-B3EC-4A1B-81CD-2CCE9C1EA59A Q24243981-E9EC7769-8630-4B62-9E98-1C7A35444C8D Q24244047-3B223055-FD1E-45BA-8E5E-C3E85CB35F92 Q24244061-5A35E4F4-AB9B-4573-B2E9-AB760739DC9B Q24244289-7A9DC95D-AC5B-4E90-86E8-DC5801371ABD Q24244328-80EC412C-59E9-4818-B415-3899A1CD6941 Q24244462-0FB0E541-04CA-435F-AA27-CEF785433D9F Q24244659-F32AB647-638D-49E6-8655-8BF0BD937C15 Q24244747-5B009908-598B-4A20-921D-00CABCE99FE3 Q24244845-1B578F52-87EF-4AD3-827C-01B0DF0BC32C Q24244883-38068A71-B50D-4352-9D9C-58AAEFC65A3B Q24244900-ED6D80D8-39EA-4664-9372-DF89FD74A096

P2860

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

http://www.wikidata.org/entity/Q28258215

description

1994 nî lūn-bûn

@nan

1994 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Lifetime and 12-month prevalen ...... he National Comorbidity Survey

@ast

Lifetime and 12-month prevalen ...... he National Comorbidity Survey

@en

Lifetime and 12-month prevalen ...... he National Comorbidity Survey

@nl

type

label

Lifetime and 12-month prevalen ...... he National Comorbidity Survey

@ast

Lifetime and 12-month prevalen ...... he National Comorbidity Survey

@en

Lifetime and 12-month prevalen ...... he National Comorbidity Survey

@nl

prefLabel

Lifetime and 12-month prevalen ...... he National Comorbidity Survey

@ast

Lifetime and 12-month prevalen ...... he National Comorbidity Survey

@en

Lifetime and 12-month prevalen ...... he National Comorbidity Survey

@nl

P1433

Q28258215-450C04BC-6DAB-48DF-B1DC-CE292DA0DBF4

P1476

Q28258215-0DD49466-2348-4A77-B87E-D032ED211B9F

P2093

Q28258215-43337AC9-ED32-49AC-AC7F-ECD2E1F43707

Q28258215-54928439-5A06-4995-A77B-9A282B844BCA

Q28258215-77F5EAFB-6232-46A8-9D05-D67EBAA3A3B2

Q28258215-9E7A570C-E15F-4738-9BAD-1D9F85DA6F1E

Q28258215-E13FE6FA-FE16-4638-BCF1-0F40356EDE0C

Q28258215-EBB5F9D3-90BF-4AF0-BB83-88CA94957375

P304

Q28258215-86AFE4EC-3614-4045-AE83-D580499B2B61

P31

Q28258215-26EB57C5-F082-4D36-A0B4-D3C33FD67E06

P3181

Q28258215-8AB1CBF4-BB7B-41AC-92C6-75BD36993573

P356

Q28258215-75F04A5E-D2BF-4239-B776-7D23B10B2943

P407

Q28258215-CF5121DA-C0BF-4A86-AB21-9C42B8B1DB74

P433

Q28258215-1C83F28E-00EB-4F75-9FC0-F7C5DBDB5292

P478

Q28258215-75EB8AA4-8867-4989-A1EA-4CE368BEB681

P50

Q28258215-A778D613-D82E-4A3D-8E3C-16FA3D04061A

Q28258215-C6B3D03F-8519-4723-8D49-16F401E73BAB

P577

Q28258215-63859E6D-B158-4209-AD4B-759A56DBDEAD

P698

Q28258215-D13862D3-3881-4A72-967A-10DCEC24BACB

P921

Q28258215-E1E657EE-695D-4AA1-B3AA-95A8CF3AF8D7

P3181

P356

ARCHPSYC.1994.03950010008002

P1433

JAMA Psychiatry

P1476

Lifetime and 12-month prevalen ...... he National Comorbidity Survey

@en

P2093

C B Nelson

http://www.w3.org/2001/XMLSchema#string

K A McGonagle

http://www.w3.org/2001/XMLSchema#string

M Hughes

http://www.w3.org/2001/XMLSchema#string

R C Kessler

http://www.w3.org/2001/XMLSchema#string

S Eshleman

http://www.w3.org/2001/XMLSchema#string

S Zhao

http://www.w3.org/2001/XMLSchema#string

P304

8-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

518666

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/ARCHPSYC.1994.03950010008002

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Hans-Ulrich Wittchen

Kenneth S. Kendler

P577

1994-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8279933

http://www.w3.org/2001/XMLSchema#string

P921